Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 72162-1527

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 72162-1527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)
Chemical structure of bupropion hydrochloride showing a chlorophenyl group attached to a side chain with ketone and tertiary amine groups, accompanied by the hydrochloride (HCl) designation.*
FDA Label Image

Image Description (Lbl721621527)

Image Description (Lbl721621527)
Label for Bupropion Hydrochloride Extended-Release Tablets USP (XL) 300 mg, film-coated oral tablets. The label indicates a package of 500 tablets, relabeled by Bryant Ranch Prepack, Inc. and manufactured by ScieGen Pharmaceuticals, Inc. It includes storage instructions and warnings, along with barcodes and the product NDC 72162-1527-5.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.